Beyond insulin resistance in NASH: TNF-alpha or adiponectin? (Q47236730)

12 January 2018

title

Beyond insulin resistance in NASH: TNF-alpha or adiponectin? (English)

1 reference

12 January 2018

0 references

1 reference

1 reference

James G Kench

4

0 references

author name string

Jason M Hui

1

1 reference

12 January 2018

Alex Hodge

2

1 reference

12 January 2018

Geoffrey C Farrell

3

1 reference

12 January 2018

Adamandia Kriketos

5

1 reference

12 January 2018

Jacob George

6

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

12 January 2018

published in

Hepatology

1 reference

12 January 2018

volume

40

1 reference

12 January 2018

page(s)

46-54

1 reference

12 January 2018

issue

1

1 reference

12 January 2018

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

cites work

1 reference

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

Statistical Methods in Medical Research

21 January 2018

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

7 January 2021

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

1 reference

7 January 2021

Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

7 January 2021

Clear messages from sonographic shadows? Links between metabolic disorders and liver disease, and what to do about them.

1 reference

7 January 2021

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

7 January 2021

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

7 January 2021

NASH--hepatic metabolism and not simply the metabolic syndrome

1 reference

7 January 2021

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

1 reference

7 January 2021

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

1 reference

7 January 2021

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

7 January 2021

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

7 January 2021

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

7 January 2021

Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance

1 reference

7 January 2021

Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

1 reference

7 January 2021

Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.

1 reference

7 January 2021

Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects

1 reference

7 January 2021

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

1 reference

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

7 January 2021

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

1 reference

7 January 2021

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

1 reference

7 January 2021

Decreased plasma adiponectin concentrations in women with dyslipidemia

1 reference

7 January 2021

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

1 reference

7 January 2021

HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity

1 reference

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

7 January 2021

Nonalcoholic steatohepatitis: definition and pathology

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas

1 reference

7 January 2021

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

7 January 2021

Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients

1 reference

7 January 2021

Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance.

1 reference

7 January 2021

Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules.

1 reference

7 January 2021

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

7 January 2021

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

7 January 2021

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

1 reference

7 January 2021

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

7 January 2021

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

7 January 2021

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

1 reference

7 January 2021

Effect of weight reduction on hepatic abnormalities in overweight patients.

1 reference

7 January 2021

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20280

1 reference

12 January 2018

PubMed ID

15239085

1 reference

12 January 2018